Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Receivables (2023 - 2025)

CervoMed's Change in Receivables history spans 4 years, with the latest figure at -$999588.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 478.42% year-over-year to -$999588.0; the TTM value through Sep 2025 reached $1.1 million, up 315.39%, while the annual FY2024 figure was $1.3 million, 46.26% up from the prior year.
  • Change in Receivables for Q3 2025 was -$999588.0 at CervoMed, down from $731748.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.0 million in Q4 2024 and bottomed at -$999588.0 in Q3 2025.
  • The 3-year median for Change in Receivables is $264148.0 (2024), against an average of $194483.9.
  • The largest annual shift saw Change in Receivables soared 117.4% in 2024 before it crashed 478.42% in 2025.
  • A 3-year view of Change in Receivables shows it stood at $915404.0 in 2023, then skyrocketed by 117.4% to $2.0 million in 2024, then crashed by 150.23% to -$999588.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Change in Receivables are -$999588.0 (Q3 2025), $731748.0 (Q2 2025), and -$625004.0 (Q1 2025).